Last reviewed · How we verify

NCT03984773

Machine-Generated Mortality Estimates and Nudges to Promote Advance Care Planning Discussion Among Cancer Patients

Completed NA Last updated 24 April 2020
What this trial tests

NA trial testing Nudge in Oncology in 78 participants. Completed in 19 April 2020.

Timeline
15 July 2019
Primary endpoint
1 November 2019
19 April 2020

Quick facts

Lead sponsorUniversity of Pennsylvania
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposehealth services research
Enrollment78
Start date15 July 2019
Primary completion1 November 2019
Estimated completion19 April 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Pennsylvania

Who can join

18 and older, any sex, with Oncology. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will use a stepped-wedge cluster randomized trial to evaluate the effect of a health system initiative using machine learning algorithms and behavioral nudges to prompt oncologists to have serious illness conversations with patients at high-risk of short-term mortality.

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Effect of Integrating Machine Learning Mortality Estimates With Behavioral Nudges to Clinicians on Serious Illness Conversations Among Patients With Cancer: A Stepped-Wedge Cluster Randomized Clinical Trial.
    Manz CR, Parikh RB, Small DS, Evans CN, et al · · 2020 · cited 131× · PMID 33057696 · DOI 10.1001/jamaoncol.2020.4759
  2. Long-term Effect of Machine Learning-Triggered Behavioral Nudges on Serious Illness Conversations and End-of-Life Outcomes Among Patients With Cancer: A Randomized Clinical Trial.
    Manz CR, Zhang Y, Chen K, Long Q, et al · · 2023 · cited 84× · PMID 36633868 · DOI 10.1001/jamaoncol.2022.6303
  3. Oncologist Perceptions of Algorithm-Based Nudges to Prompt Early Serious Illness Communication: A Qualitative Study.
    Parikh RB, Manz CR, Nelson MN, Ferrell W, et al · · 2022 · cited 13× · PMID 35984992 · DOI 10.1089/jpm.2022.0095
  4. Integrating machine-generated mortality estimates and behavioral nudges to promote serious illness conversations for cancer patients: Design and methods for a stepped-wedge cluster randomized controlled trial.
    Manz CR, Parikh RB, Evans CN, Chivers C, et al · · 2020 · cited 11× · PMID 31982648 · DOI 10.1016/j.cct.2020.105951
  5. Oncologist phenotypes and associations with response to a machine learning-based intervention to increase advance care planning: Secondary analysis of a randomized clinical trial.
    Li E, Manz C, Liu M, Chen J, et al · · 2022 · cited 10× · PMID 35622812 · DOI 10.1371/journal.pone.0267012
  6. Impact of Behavioral Nudges on the Quality of Serious Illness Conversations Among Patients With Cancer: Secondary Analysis of a Randomized Controlled Trial.
    Li EH, Ferrell W, Klaiman T, Kumar P, et al · · 2022 · cited 6× · PMID 34767481 · DOI 10.1200/op.21.00024
  7. Spending Analysis of Machine Learning-Based Communication Nudges in Oncology.
    Patel TA, Heintz J, Chen J, LaPergola M, et al · · 2024 · cited 5× · PMID 39036423 · DOI 10.1056/aioa2300228
  8. Clinician- and Patient-Directed Communication Strategies for Patients With Cancer at High Mortality Risk: A Cluster Randomized Trial.
    Takvorian SU, Gabriel P, Wileyto EP, Blumenthal D, et al · · 2024 · cited 5× · PMID 38949813 · DOI 10.1001/jamanetworkopen.2024.18639

Verify or expand the search:

Other trials of Nudge

Trials testing the same drug.

Other recruiting trials for Oncology

Currently open trials in the same condition.

Other University of Pennsylvania trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03984773.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing